Global Blood Plasma Market: Industry Analysis & Outlook (2018-2022)
Plasma forms 50% of the composition of blood in humans. Blood plasma is crucial because it is composed of different proteins. These plasma proteins or derivatives are extracted via a process known as fractionation. These proteins have high therapeutic value because they are used in several indications and its new uses are still being explored. Of these proteins, albumin accounts highest share that is 60%, and immunoglobulin with 15% share. These two are the most common proteins extracted to treat various disease.
Blood plasma is important because it fights off foreign substances that invade the body and transport nutrients and water. North America is the largest market for blood plasma as it has the most advanced infrastructure which has helped in increasing plasma collection over the time. However, emerging economies like that of China have showed huge potential with increased imports of Albumin.
Growth factors of the global blood plasma market include progress in therapeutic protein development, new advances in production of plasma, rise in collection centers, and growing Alpha-1 market’s potential. Major trends of the market include increase in fractionation capacity, growing AATD market potential, and innovation in therapeutics. The market growth is hindered by factors such as high cost of treatment, and high R&D costs.
The report offers an in-depth analysis of the global blood plasma market. It also covers global as well as regional aspect of the market. The competitive landscape of the market is of oligopoly form with domination of major players globally. The report profiles the top notch players of the market including Shire Plc., CSL Limited, Grifols, S.A., and Octapharma Inc.
Blood plasma is important because it fights off foreign substances that invade the body and transport nutrients and water. North America is the largest market for blood plasma as it has the most advanced infrastructure which has helped in increasing plasma collection over the time. However, emerging economies like that of China have showed huge potential with increased imports of Albumin.
Growth factors of the global blood plasma market include progress in therapeutic protein development, new advances in production of plasma, rise in collection centers, and growing Alpha-1 market’s potential. Major trends of the market include increase in fractionation capacity, growing AATD market potential, and innovation in therapeutics. The market growth is hindered by factors such as high cost of treatment, and high R&D costs.
The report offers an in-depth analysis of the global blood plasma market. It also covers global as well as regional aspect of the market. The competitive landscape of the market is of oligopoly form with domination of major players globally. The report profiles the top notch players of the market including Shire Plc., CSL Limited, Grifols, S.A., and Octapharma Inc.
1. MARKET OVERVIEW
1.1 Blood Plasma
1.2 Blood Plasma Derivatives
1.3 Functions of Blood Plasma
1.4 Plasma Collection
2. GLOBAL MARKET ANALYSIS
2.1 Global Blood Plasma Market by Value
2.2 Global Blood Plasma Market Forecast by Value
2.3 Global Blood Plasma Fractionation Capacity
2.4 Global Blood Plasma Fractionation Capacity Forecast
2.5 Global Blood Plasma Market by Type
2.6 Global Blood Plasma Market Forecast by Type
2.7 Global Immunoglobulin Market
2.7.1 Global Immunoglobulin Market Forecast by Value
2.7.2 Global Immunoglobulin Market Forecast by Volume
2.7.3 Global Immunoglobulin Market Volume by Region
2.7.4 Global Immunoglobulin Market by Types
2.7.5 Global Immunoglobulin Population by Indication
2.8 Global Albumin Market
2.8.1 Global Albumin Market Forecast by Value
2.8.1 Global Albumin Market Forecast by Volume
2.8.3 Global Albumin Market Volume by Region
2.9 Global Factor VIII Market
2.9.1 Global Factor VIII Market Forecast by Value
2.9.2 Global Factor VIII Market Forecast by Volume
2.10 Global Alpha 1 Market
2.10.1 Global Alpha 1 Market Forecast by Value
2.11 Global Blood Plasma Market by Region
3. REGIONAL ANALYSIS
3.1 North America
3.1.1 North America’s Blood Plasma Market Forecast by Value
3.1.2 North America’s Blood Plasma Market by Type
3.1.3 The US Blood Plasma Market
3.1.4 The US Immunoglobulin Market Forecast by Value & Volume
3.1.5 The US Immunoglobulin Market Volume by Segment
3.1.6 The US Albumin Market Forecast by Volume
3.2 Europe
3.2.1 Europe Blood Plasma Market Forecast by Value
3.3 APAC
3.3.1 Asia-Pacific Blood Plasma Market Forecast by Value
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Recent Progress in Therapeutic Protein Drug Development
4.1.2 New Developments in the Production of Plasma Derivatives
4.1.3 Increasing Plasma Collection
4.1.4 Increased Diagnosis of Disease Treated by Immunoglobulin
4.1.5 Increase in Per Capita use of Immunoglobulin
4.1.6 Popularity of Albumin in Asian Countries
4.1.7 Rise in GDP Per Capita
4.1.8 Increased Spending on Medicines
4.1.9 Increasing Global Healthcare Expenditure
4.1.10 Escalating Ageing Population
4.2 Trends & Developments
4.2.1 Increasing Fractionation Capacity
4.2.2 Growing AATD Market Potential
4.2.3 Growing Blood Plasma Market in Emerging Economies
4.3 Challenges & Issues
4.3.1 High Barriers to Entry
4.3.2 Challenging to Open New Plasma Centers
4.3.3 High R&D Costs
5. COMPETITIVE LANDSCAPE
5.1 Global Market
5.1.1 Global Blood Plasma Market Share
5.1.2 Global Blood Plasma Market-Comparative Analysis of Major Players
5.1.3 Global Immunoglobulin Market Share
5.1.4 Global Albumin Market Share
5.1.5 Global Plasma-Derived Factor VIII Market Share
5.1.6 Global Alpha1 Market Share
5.1.7 Growth in Plasma Collection by Leading Players
5.2 The US
5.2.1 The US Blood Plasma Collection Centers by Major Players
5.2.2 The US Blood Plasma Collection Volume by Major Players
6. COMPANY PROFILES
6.1 Shire Plc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 CSL Limited
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Grifols, S.A.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Octapharma, Inc.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
1.1 Blood Plasma
1.2 Blood Plasma Derivatives
1.3 Functions of Blood Plasma
1.4 Plasma Collection
2. GLOBAL MARKET ANALYSIS
2.1 Global Blood Plasma Market by Value
2.2 Global Blood Plasma Market Forecast by Value
2.3 Global Blood Plasma Fractionation Capacity
2.4 Global Blood Plasma Fractionation Capacity Forecast
2.5 Global Blood Plasma Market by Type
2.6 Global Blood Plasma Market Forecast by Type
2.7 Global Immunoglobulin Market
2.7.1 Global Immunoglobulin Market Forecast by Value
2.7.2 Global Immunoglobulin Market Forecast by Volume
2.7.3 Global Immunoglobulin Market Volume by Region
2.7.4 Global Immunoglobulin Market by Types
2.7.5 Global Immunoglobulin Population by Indication
2.8 Global Albumin Market
2.8.1 Global Albumin Market Forecast by Value
2.8.1 Global Albumin Market Forecast by Volume
2.8.3 Global Albumin Market Volume by Region
2.9 Global Factor VIII Market
2.9.1 Global Factor VIII Market Forecast by Value
2.9.2 Global Factor VIII Market Forecast by Volume
2.10 Global Alpha 1 Market
2.10.1 Global Alpha 1 Market Forecast by Value
2.11 Global Blood Plasma Market by Region
3. REGIONAL ANALYSIS
3.1 North America
3.1.1 North America’s Blood Plasma Market Forecast by Value
3.1.2 North America’s Blood Plasma Market by Type
3.1.3 The US Blood Plasma Market
3.1.4 The US Immunoglobulin Market Forecast by Value & Volume
3.1.5 The US Immunoglobulin Market Volume by Segment
3.1.6 The US Albumin Market Forecast by Volume
3.2 Europe
3.2.1 Europe Blood Plasma Market Forecast by Value
3.3 APAC
3.3.1 Asia-Pacific Blood Plasma Market Forecast by Value
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Recent Progress in Therapeutic Protein Drug Development
4.1.2 New Developments in the Production of Plasma Derivatives
4.1.3 Increasing Plasma Collection
4.1.4 Increased Diagnosis of Disease Treated by Immunoglobulin
4.1.5 Increase in Per Capita use of Immunoglobulin
4.1.6 Popularity of Albumin in Asian Countries
4.1.7 Rise in GDP Per Capita
4.1.8 Increased Spending on Medicines
4.1.9 Increasing Global Healthcare Expenditure
4.1.10 Escalating Ageing Population
4.2 Trends & Developments
4.2.1 Increasing Fractionation Capacity
4.2.2 Growing AATD Market Potential
4.2.3 Growing Blood Plasma Market in Emerging Economies
4.3 Challenges & Issues
4.3.1 High Barriers to Entry
4.3.2 Challenging to Open New Plasma Centers
4.3.3 High R&D Costs
5. COMPETITIVE LANDSCAPE
5.1 Global Market
5.1.1 Global Blood Plasma Market Share
5.1.2 Global Blood Plasma Market-Comparative Analysis of Major Players
5.1.3 Global Immunoglobulin Market Share
5.1.4 Global Albumin Market Share
5.1.5 Global Plasma-Derived Factor VIII Market Share
5.1.6 Global Alpha1 Market Share
5.1.7 Growth in Plasma Collection by Leading Players
5.2 The US
5.2.1 The US Blood Plasma Collection Centers by Major Players
5.2.2 The US Blood Plasma Collection Volume by Major Players
6. COMPANY PROFILES
6.1 Shire Plc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 CSL Limited
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Grifols, S.A.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Octapharma, Inc.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
LIST OF CHARTS
Components of Blood Plasma
Plasma Fractioned to Protein
Global Blood Plasma Market by Value (2013-2017)
Global Blood Plasma Market Forecast by Value (2018-2022)
Global Blood Plasma Fractionation Capacity (2013-2017)
Global Blood Plasma Fractionation Capacity Forecast (2018-2022)
Global Blood Plasma Market by Type (2017)
Global Blood Plasma Market Forecast by Type (2022)
Global Immunoglobulin Market Forecast by Value (2017-2022)
Global Immunoglobulin Market Forecast by Volume (2017-2022)
Global Immunoglobulin Market Volume by Region (2017)
Global Immunoglobulin Market by Types (2017)
Global Immunoglobulin Population by Indication (2017)
Global Albumin Market Forecast by Value (2017-2022)
Global Albumin Market Forecast by Volume (2017-2022)
Global Albumin Market Volume by Region (2017)
Global Factor VIII Market Forecast by Value (2017-2022)
Global Factor VIII Market Forecast by Volume (2017-2022)
Global Alpha 1 Market Forecast by Value (2017-2022)
Global Blood Plasma Market by Region (2017)
North America’s Blood Plasma Market Forecast by Value (2017-2022)
North America’s Blood Plasma Market by Type (2017)
The US Immunoglobulin Market Forecast by Value & Volume (2017-2022)
The US Immunoglobulin Market Volume by Segment (2017)
The US Albumin Market Forecast by Volume (2017-2022)
Europe Blood Plasma Market Forecast by Value (2017-2022)
Asia-Pacific Blood Plasma Market Forecast by Value (2017-2022)
Plasma Collection in the US (2013-2017)
Per Capita use of Immunoglobulin by Region (2017)
Albumin Consumption Per Capita by Country (2017)
Global GDP Per Capita (2013-2017)
Global Spending on Medicines (2010-2020)
Global Healthcare Expenditure (2013-3017)
Global Ageing Population of 60 Years or Older (2000-2030)
Global Alpha1 Patient Population (2017)
Global Blood Plasma Market Share by Company (2017)
Global Immunoglobulin Market Share by Company (2017)
Global Albumin Market Share by Company (2017)
Global Plasma-Derived Factor VIII Market Share by Company (2017)
Global Alpha1 Market Share by Company (2017)
Growth in Plasma Collection by Leading Players (2017)
The US Blood Plasma Collection Centers by Major Players (2014-2017)
The US Blood Plasma Collection Volume by Major Players (2014-2017)
Shire Plc. Revenue Share by Product (2017)
Shire PLC’s Revenue and Net Income (2013-2017)
CSL Limited’s Revenue Share by Products (2017)
CSL Limited’s Revenue and Net Profit (2013-2017)
Research & Development Investments of CSL Limited (2013-2017)
Grifols, S.A. Revenue Share by Business Segments (2017)
Grifols, S.A. Revenue and Gross Profit (2013-2017)
Octapharma, Inc. Revenue (2013-2017)
Components of Blood Plasma
Plasma Fractioned to Protein
Global Blood Plasma Market by Value (2013-2017)
Global Blood Plasma Market Forecast by Value (2018-2022)
Global Blood Plasma Fractionation Capacity (2013-2017)
Global Blood Plasma Fractionation Capacity Forecast (2018-2022)
Global Blood Plasma Market by Type (2017)
Global Blood Plasma Market Forecast by Type (2022)
Global Immunoglobulin Market Forecast by Value (2017-2022)
Global Immunoglobulin Market Forecast by Volume (2017-2022)
Global Immunoglobulin Market Volume by Region (2017)
Global Immunoglobulin Market by Types (2017)
Global Immunoglobulin Population by Indication (2017)
Global Albumin Market Forecast by Value (2017-2022)
Global Albumin Market Forecast by Volume (2017-2022)
Global Albumin Market Volume by Region (2017)
Global Factor VIII Market Forecast by Value (2017-2022)
Global Factor VIII Market Forecast by Volume (2017-2022)
Global Alpha 1 Market Forecast by Value (2017-2022)
Global Blood Plasma Market by Region (2017)
North America’s Blood Plasma Market Forecast by Value (2017-2022)
North America’s Blood Plasma Market by Type (2017)
The US Immunoglobulin Market Forecast by Value & Volume (2017-2022)
The US Immunoglobulin Market Volume by Segment (2017)
The US Albumin Market Forecast by Volume (2017-2022)
Europe Blood Plasma Market Forecast by Value (2017-2022)
Asia-Pacific Blood Plasma Market Forecast by Value (2017-2022)
Plasma Collection in the US (2013-2017)
Per Capita use of Immunoglobulin by Region (2017)
Albumin Consumption Per Capita by Country (2017)
Global GDP Per Capita (2013-2017)
Global Spending on Medicines (2010-2020)
Global Healthcare Expenditure (2013-3017)
Global Ageing Population of 60 Years or Older (2000-2030)
Global Alpha1 Patient Population (2017)
Global Blood Plasma Market Share by Company (2017)
Global Immunoglobulin Market Share by Company (2017)
Global Albumin Market Share by Company (2017)
Global Plasma-Derived Factor VIII Market Share by Company (2017)
Global Alpha1 Market Share by Company (2017)
Growth in Plasma Collection by Leading Players (2017)
The US Blood Plasma Collection Centers by Major Players (2014-2017)
The US Blood Plasma Collection Volume by Major Players (2014-2017)
Shire Plc. Revenue Share by Product (2017)
Shire PLC’s Revenue and Net Income (2013-2017)
CSL Limited’s Revenue Share by Products (2017)
CSL Limited’s Revenue and Net Profit (2013-2017)
Research & Development Investments of CSL Limited (2013-2017)
Grifols, S.A. Revenue Share by Business Segments (2017)
Grifols, S.A. Revenue and Gross Profit (2013-2017)
Octapharma, Inc. Revenue (2013-2017)
LIST OF TABLES
Blood Plasma Protein Breakup
Functions of Blood Plasma
The US Blood Plasma Market by Key Parameters (2017)
Protein Engineering Platform Technologies (2017)
The US Food and Drug Administration-Approved Protein Therapeutics (2016)
The US CIDP Market (2017)
Fractionation Capacity of Key Market Players (2013-2022)
Global Blood Plasma Market-Comparative Analysis of Major Players (2017)
Shire PLC’s Major Product Pipeline (2017)
Octapharma, Inc. Product Pipeline (2017)
Blood Plasma Protein Breakup
Functions of Blood Plasma
The US Blood Plasma Market by Key Parameters (2017)
Protein Engineering Platform Technologies (2017)
The US Food and Drug Administration-Approved Protein Therapeutics (2016)
The US CIDP Market (2017)
Fractionation Capacity of Key Market Players (2013-2022)
Global Blood Plasma Market-Comparative Analysis of Major Players (2017)
Shire PLC’s Major Product Pipeline (2017)
Octapharma, Inc. Product Pipeline (2017)
